Enhanced Assessment of the Health Status of Vaccine Protected Personnel At-Risk to Multiple Biowarfare Agents Using a Novel, Web-Based Clinical Data Management System (CDMS)
Abstract
The Special Immunization Program (SIP) Clinic at the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) provides investigational vaccines developed as potential biological defense products for Armed Forces personnel. These investigational products are used as adjunct protection for potential occupational exposures to at risk workers at USAMRIID under strict Food and Drug Administration (FDA) clinical research regulations. The program offers unique immunization and occupational health services for in-house laboratory staff, as well as for deployed military personnel and other Federal employees who are at risk of exposure to certain biological threat agents.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2004
- Accession Number
- ADA433684
Entities
People
- Brad Goebel
- Ellen Boudreau
- Heidi Moynihan
- J. E. Brown
- Jeannine Haller
- John Aldis
- Mark Kortepeter
- Michael J. Mccreery
- Patricia Petitt
- Susan C. Mayer
Organizations
- United States Army Medical Research Institute of Infectious Diseases